Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
37.08
-0.38 (-1.01%)
At close: Mar 6, 2026, 4:00 PM EST
37.80
+0.72 (1.94%)
After-hours: Mar 6, 2026, 7:36 PM EST

Cogent Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
312.0198.1753.23139.89219.68
Short-Term Investments
588.75188.91212.48119.39-
Cash & Short-Term Investments
900.77287.08265.71259.28219.68
Cash Growth
213.77%8.04%2.48%18.02%-9.29%
Other Current Assets
9.599.45.065.692.95
Total Current Assets
910.36296.47270.77264.97222.63
Net Property, Plant & Equipment
23.5426.5630.3431.14.48
Long-Term Investments
--7.46--
Other Long-Term Assets
3.724.864.864.754.98
Total Assets
937.61327.9313.44300.81232.09
Accounts Payable
9.512.0110.665.843.48
Accrued Expenses
52.942.1326.1317.888.21
Current Portion of Leases
1.551.571.391.422.32
Other Current Liabilities
---1.73.06
Total Current Liabilities
63.9555.7138.1726.8517.08
Long-Term Debt
222.9----
Long-Term Leases
14.3615.917.4718.230.83
Other Long-Term Liabilities
0.03----
Total Long-Term Liabilities
237.2815.917.4718.230.83
Total Liabilities
301.2471.6155.6445.0817.91
Preferred Stock
89.39110.660.0465.8385.4
Common Stock
0.160.110.090.070.04
Additional Paid-in Capital
1,7351,005801.06601.15399.71
Accumulated Other Comprehensive Income
0.360.450.25-0.1-
Retained Earnings
-1,188-859.48-603.62-411.21-270.97
Shareholders' Equity
636.37256.29257.8255.74214.18
Total Liabilities & Equity
937.61327.9313.44300.81232.09
Total Debt
238.817.4718.8519.653.16
Net Cash (Debt)
661.97269.61246.86239.63216.53
Net Cash Growth
145.53%9.22%3.02%10.67%-8.63%
Net Cash Per Share
5.142.603.104.085.59
Book Value
636.37256.29257.8255.74214.18
Book Value Per Share
4.942.473.244.355.53
Tangible Book Value
636.37256.29257.8255.74214.18
Tangible Book Value Per Share
4.942.473.244.355.53
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q